Search Results 31-40 of 16470 for hemophilia
Antihemophilic factor (recombinant) pegylated-aucl injection is used to treat and control bleeding in patients with hemophilia A (congenital Factor VIII ...
It holds promise as a treatment for a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS. The U.S. Food ...
Hemophilia. These services are provided through the Mayo Clinic Special Coagulation Laboratories, the Coagulation Clinic and Coagulation Consulting Group ...
This inherited clotting disorder can increase your chance of developing abnormal blood clots, most commonly in your legs or lungs.
The primary objectives of this study are to obtain serological bone turnover markers and bone mineral density (BMD) measurements from hemophilia A and von ...
Low levels of the cells that help blood clot, also known as platelets, most often cause the bleeding. Once known as idiopathic thrombocytopenic purpura, ITP can ...
... Hemophilia, and the Hemophilia Treatment Center Network. He has also contributed to the literature on hematology and coagulation with various journal ...
... Hemophilia, Bleed...ing disorder, Benign hematologic condition, Hereditary ... Marshall, M.D.. Oncologist; Internist; Hematologist. Areas of focus: von Willebrand ...
... hemophilia B (congenital Factor IX deficiency or Christmas disease). Factor IX is a protein that is produced naturally in the body. This medicine is a man ...
... hemophilia B (congenital Factor IX deficiency). Factor IX is a protein that is produced naturally in the body. Alprolix® is a man-made protein produced to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.